Cargando…
Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational Study
BACKGROUND: Emerging HIV drug resistance caused by increased usage of antiretroviral drugs (ARV) could jeopardize the success of standardized HIV management protocols in resource-limited settings. OBJECTIVE: We aimed to characterize pretreatment HIV drug resistance (PDR) among HIV-positive individua...
Autores principales: | Chen, Hongli, Hao, Jingjing, Hu, Jing, Song, Chang, Zhou, Yesheng, Li, Miaomiao, Chen, Jin, Liu, Xiu, Wang, Dong, Xu, Xiaoshan, Xin, Peixian, Zhang, Jiaxin, Liao, Lingjie, Feng, Yi, Li, Dan, Pan, Stephen W, Shao, Yiming, Ruan, Yuhua, Xing, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692882/ https://www.ncbi.nlm.nih.gov/pubmed/37976080 http://dx.doi.org/10.2196/50894 |
Ejemplares similares
-
Molecular transmission network of pretreatment drug resistance among human immunodeficiency virus-positive individuals and the impact of virological failure on those who received antiretroviral therapy in China
por: Chen, Hongli, et al.
Publicado: (2022) -
Survey of pretreatment HIV drug resistance and the genetic transmission networks among HIV-positive individuals in southwestern China, 2014–2020
por: Xu, Xiaoshan, et al.
Publicado: (2021) -
Survey of Pretreatment HIV Drug Resistance and Genetic Transmission Network Analysis Among HIV Patients in a High Drug-Use Area of Southwest China
por: Liu, Lei, et al.
Publicado: (2019) -
Impact of HIV Pretreatment Drug Resistance on Virological Failure After One-Year Antiretroviral Therapy — China, 2018–2019
por: Li, Miaomiao, et al.
Publicado: (2022) -
HIV transmission and associated factors under the scale-up of HIV antiretroviral therapy: a population-based longitudinal molecular network study
por: Chen, Yi, et al.
Publicado: (2023)